Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bellevue Group (BBN) Fair Value & Analysis

Financial Services · CH · Market cap CHF 99.8M

PriceCHF 6.84
Fair ValueCHF 2.40
Upside-64.9%
Quality95/100
Evidence: High Range CHF 1.80 – CHF 3.00

Fair value as of: Jun 26, 2026

Analysis

Bellevue Group (BBN) currently trades at CHF 6.84, while our model-based Fair Value estimate is CHF 2.40 — implying the stock looks roughly 64.9% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid-caps, and private equity strategies; and multi asset and bond solutions. The company was founded in 1993 and is headquartered in Zurich, Switzerland.

Open the full interactive analysis →

Similar stocks

Fondul Proprietatea SA (FP) +90% The Schiehallion Fund Limited (MNTN) +87% BlackRock, Inc (BLK) -97% BH Macro Limited (BHMU) +100% Blackstone Inc (BX) -56% Investor AB (IVSBF) +100%

Frequently asked questions

Is Bellevue Group (BBN) undervalued?
As of Jun 26, 2026, our model estimates a fair value of CHF 2.40 versus a price of CHF 6.84 — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BBN?
Our 21-model fair value for Bellevue Group is CHF 2.40 (as of Jun 26, 2026), built from audited fundamentals. The current price is CHF 6.84.
What is the quality score of BBN?
Bellevue Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.